论文部分内容阅读
贝伐单抗联合铂类治疗晚期NSCLC疗效与安全性Meta分析
【机 构】
：
浙江中医药大学第一临床医学院,杭州,浙江,310053
【出 处】
：
华东抗肿瘤药物研究新进展与肿瘤精准治疗论坛
【发表日期】
：
2015年期
其他文献
Objective: Epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI)therapy is considered as one of the most important treatments for patients wi
会议
Background: The expression of TG2 is correlation to DNA damage repair and apoptosis through P53 pathway which influences the radiosensitivity.The present st
会议
Objective: Retinoic acid receptor alpha(RARα)plays a critical role in the differentiation process of osteosarcoma cells induced by all-trans retinoic acid(
会议
Background: Standardized chemotherapy used in cancer patients with severe kidney insufficiency is incon clusive.Although some pharmacokinetic studies of cyc
会议
The tradition chemotherapy for patients with advanced breast cancer has sever toxicity and poor curative effect.Metronomic chemotherapy is a kind of ‘low d
会议
Objectives: The aim of this study is to explore the Keap1-Nrf2 balance in tumor proliferation,drug resistance and invasion,by using the Keap1-overexpressing